Mark Fitzpatrick
2014 - Aegerion Pharmaceuticals
In 2014, Mark Fitzpatrick earned a total compensation of $1.5M as former Chief Financial Officer at Aegerion Pharmaceuticals, a 19% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,141,936 |
|---|---|
| Salary | $370,500 |
| Other | $7,800 |
| Total | $1,520,236 |
Fitzpatrick received $1.1M in option awards, accounting for 75% of the total pay in 2014.
Fitzpatrick also received $370.5K in salary and $7.8K in other compensation.
Rankings
In 2014, Mark Fitzpatrick's compensation ranked 5,679th out of 13,032 executives tracked by ExecPay. In other words, Fitzpatrick earned more than 56.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,679 out of 13,032 | 56th |
Division Manufacturing | 2,038 out of 4,966 | 59th |
Major group Chemicals And Allied Products | 690 out of 1,686 | 59th |
Industry group Drugs | 536 out of 1,365 | 61st |
Industry Pharmaceutical Preparations | 412 out of 1,043 | 61st |
Source: SEC filing on April 29, 2016.
Fitzpatrick's colleagues
We found four more compensation records of executives who worked with Mark Fitzpatrick at Aegerion Pharmaceuticals in 2014.